Skip to main content

Table 1 General and clinical information of participants

From: The correlation between serum total bile acid and alanine aminotransferase of pregnant women and the disorders of neonatal hyperbilirubinemia-related amino acid metabolism

 

Variables

No-NHB

NHB

p-value

Neonatal

n

182

51

 
 

Male neonates (n%)

104 (57.1)

26 (51.0)

0.434 b

 

Female neonates (n%)

78 (42.9)

25 (49.0)

 

Neonatal birth weight (grams)

3200(2850–3500)

2350(1650–3522)

< 0.001 a

 

Preterm (n%)

15(8.2)

30(58.8)

< 0.001 b

 

Hydramnios (n%)

15(8.2)

11(21.6)

0.008 b

Maternal

Age (years)

29.0 (27.0–32.0)

31.0 (28.0–33.0)

0.021 a

 

Pre pregnancy BMI (kg/m2)

21.0 (19.4–23.2)

21.0(19.7–23.7)

0.984 a

 

Gestational weight gain (kg)

14.8 (12.0–18.0)

12.0 (10.0–17.0)

0.046 a

 

Gestational week (week)

39.3(38.3–40.0)

36.1 (34.0–39.0)

< 0.001 a

 

Nulliparous (n%)

123 (67.6)

27 (52.9)

0.054 b

 

Cesarean section (n%)

87 (47.8)

35 (68.6)

0.008 b

 

Preeclampsia (n%)

21(11.5)

14(27.5)

0.005 b

  1. BMI, body Mass Index; NHB, neonatal hyperbilirubinemia
  2. All continuous variables in the table were given as the medians (quartile1-quartile3), the categorical variables were presented as frequency (%)
  3. The differences between the No-NHB and NHB groups were obtained using the Mann-Whitney U test (a) and the Chi-square test (b), p < 0.05 was considered to be significant